4//SEC Filing
Strem Brian M. 4
Accession 0001104659-21-098991
CIK 0001372514other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 5:30 PM ET
Size
5.6 KB
Accession
0001104659-21-098991
Insider Transaction Report
Form 4
Strem Brian M.
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2021-07-26+100,000→ 100,000 totalExercise: $3.12Exp: 2031-07-26→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on July 26, 2022, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001876429
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 5:30 PM ET
- Size
- 5.6 KB